Similar Articles
1331 Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma
1332 Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet
1333 Strategies to increase the resectability of hepatocellular carcinoma
1334 Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
1335 Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure
1336 Immunology of hepatocellular carcinoma
1337 Addiction specialist's role in liver transplantation procedures for alcoholic liver disease
1338 Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma
1339 Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells
1340 Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA